NK-3

CAT # Inoa Huahana wehewehe
CPD100768 Fezolinetant ʻO Fezolinetant, ka mea i kapa ʻia ʻo ESN-364, ʻo ia ka Neurokinin-3 (NK-3) receptor antagonist i hoʻohana ʻia no ka hoʻohana ʻana i ke olakino wahine, a ke kūkulu ʻia nei no nā maʻi pili i ka sex-hormone e like me endometriosis, polycystic ovarian syndrome a me fibroids uterine. . Hiki i ka Fexolinetant ke hoʻololi i ka axis gonadal hypothalamic-pituitary me kahi hana koho i nā hormones pili i ka maʻi. Manaʻo ʻia e ʻoi aku ka ʻoi aku o ka hoʻomanawanui ma mua o nā huahana hoʻokūkū e kuhikuhi ana iā GnRH (Gonadotropin-releasing hormone).
,

Kāhea iā mā˚ou

Ninau

Nuhou Hou

  • ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

    ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

    Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

  • ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

    ARS-1620: He mea hoʻohiki hou no K...

    Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

  • Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

    Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

    Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

WhatsApp Online Chat !